QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.2    
    


FOURTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT  


        This Fourth Amended and Restated Registration Rights Agreement (this "Agreement") is entered into as of January 23, 2007 by and among Sirtris
Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), and the persons and entities listed on Schedule A hereto and certain
other persons or entities that become parties to this Agreement after the date hereof in accordance with Section 21 hereof (the "Investors"). 


        WHEREAS,
the Corporation and certain of the Investors are parties to a Third Amended and Restated Registration Rights Agreement dated as of March 14, 2006 (the "Original
Agreement"), that grants such Investors registration rights with respect to the shares of Common Stock issuable upon conversion of their shares of Series A Preferred Stock (as defined below),
Series A-1 Preferred Stock (as defined below), Series B Preferred Stock (as defined below), and Series C Preferred Stock (as defined below). 


        WHEREAS,
the Corporation and the Investors party to the Original Agreement entered into an Amendment No. 1 to the Original Agreement dated as of April 18, 2006 (together
with the Original Agreement, the "Old Agreement") in order to, among other things, grant registration rights with respect to the shares of Common Stock issuable upon conversion of (i) the
Series B Preferred Stock issuable upon exercise of warrants issued by the Corporation to Lender Warrant Holder (as defined below) and (ii) the Series C Preferred Stock issuable
upon exercise of warrants issued by the Corporation to HTGC Warrant Holder (as defined below). 


        WHEREAS,
simultaneously with the execution hereof, the Corporation is entering into a Series C-1 Convertible Preferred Stock Purchase Agreement with certain of the
Investors (the "Series C-1 Purchase Agreement"), pursuant to which the Corporation is issuing Series C-1 Preferred Stock (as defined below) to such Investors. 



        WHEREAS,
such Investors have required, as a condition to the purchase of the Series C-1 Preferred Stock pursuant to the Series C-1 Purchase
Agreement, that they be granted registration rights with respect to the shares of Common Stock
issuable upon conversion of their shares of Series C-1 Preferred Stock that are substantially the same as those granted under the Old Agreement to certain of the Investors with
respect to the shares of Common Stock issuable upon conversion of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the
Series C Preferred Stock. 



        WHEREAS,
the Old Agreement may be amended pursuant to Section 20(b) thereof with the written agreement of the Corporation and the holders of at least a majority of the voting
power of the then outstanding Registrable Shares (as defined in the Old Agreement). 


        WHEREAS,
the Corporation and Investors holding at least a majority of the voting power of the outstanding Registrable Shares (as defined in the Old Agreement) desire to amend and restate
the Old Agreement in the manner provided below, and the Investors accept the rights created pursuant hereto in lieu of the rights granted to them under the Old Agreement. 



        NOW,
THEREFORE, in consideration of the premises and the mutual agreements hereinafter set forth, the parties hereto agree to amend and restate the Old Agreement to read in its entirety
as follows: 


        SECTION
1.    Definitions.    As used in this Agreement, the following terms shall have the following meanings: 



        (a)   The
term "1934 Act" means the Securities Exchange Act of 1934, as amended. 



        (b)   The
term "Common Stock" means the Corporation's Common Stock, $.001 par value per share. 








 




        (c)   The
term "Holder" means any holder of Registrable Shares. 


        (d)   The
term "Preferred Stock" shall mean the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock, the
Series C Preferred Stock and the Series C-1 Preferred Stock. 



        (e)   The
terms "register," "registered," and "registration" refer to a registration effected by preparing and filing a registration statement in compliance with the
Securities Act and the declaration or ordering of effectiveness of such registration statement. 


        (f)    The
term "Registrable Shares" means (1) the Common Stock issuable upon conversion of the Preferred Stock, (2) any Common Stock purchased by an Investor (or
its permitted transferees) pursuant to Section 3 of the Third Amended and Restated Investor Rights Agreement of even date herewith by and among the Corporation and the Investors (or Common
Stock issuable with respect to other securities so purchased), (3) Common Stock issued or issuable upon conversion of shares of Preferred Stock issued or issuable upon the exercise of warrants
issued to the HTGC Warrant Holder, (4) other than for purposes of Section 2 and Section 11, the Common Stock issued or issuable upon the conversion of shares of Preferred Stock
issued or issuable upon exercise of warrants initially issued by the Corporation to the Warrant Holder, (5) other than for purposes of Section 2, the Common Stock issued or issuable upon
the conversion of shares of Preferred Stock issued or issuable upon the exercise of warrants issued to the Lender Warrant Holder, and (6) any Common Stock of the Corporation issued as a
dividend or other distribution with respect to, or in exchange or in replacement of, such Preferred Stock or Common Stock. 



        (g)   The
term "Rule 144" means Rule 144 promulgated under the Securities Act. 


        (h)   The
term "SEC" means the Securities and Exchange Commission. 


        (i)    The
term "Securities Act" means the Securities Act of 1933, as amended. 


        (j)    "Series A
Preferred Stock" shall mean the Corporation's Series A Convertible Preferred Stock, $.001 par value per share. 



        (k)   "Series A-1
Preferred Stock" shall mean the Corporation's Series A-1 Convertible Preferred Stock, $.001 par value per share. 


        (l)    "Series B
Preferred Stock" shall mean the Corporation's Series B Convertible Preferred Stock, $.001 par value per share. 


        (m)  "Series C
Preferred Stock" shall mean the Corporation's Series C Convertible Preferred Stock, $.001 par value per share. 


        (n)   "Series C-1
Preferred Stock" shall mean the Corporation's Series C-1 Convertible Preferred Stock, $0.001 par value per share. 


        (o)   "Warrant
Holder" shall mean ARE-770/784/790 Memorial Drive, LLC, a Delaware limited liability company. 


        (p)   The
term "HTGC Warrant Holder" means Hercules Technology Growth Capital, Inc., a Maryland corporation. 


        (q)   The
term "Lender Warrant Holder" means Silicon Valley Bank, a California corporation, or one or more other institutional lenders with whom the Company has entered into
an agreement for the financing of equipment purchased by the Company from time to time that has been approved by the Board of Directors of the Company. 




        In
addition, for purposes of all calculations and notices under this Agreement, and all other provisions of this Agreement where the context permits, a holder of Preferred Stock shall be
deemed 


2







 

the
Holder of the Registrable Shares issuable upon conversion thereof, and such Preferred Stock shall be deemed outstanding Registrable Shares hereunder. Notwithstanding the foregoing, nothing in this
Agreement shall require the Corporation actually to register any shares of Preferred Stock. 


        SECTION
2.    Request for Registration.    If at any time after the earlier to occur of (i) the fourth
anniversary of the date of this Agreement and (ii) the date six months after the closing of the first public offering of the Corporation's securities, the Corporation shall receive a written
request (specifying that it is being made pursuant to this Section 2) from one or more Holders that hold, in the aggregate, at least one-third of the then outstanding Registrable
Shares, that the Corporation file a registration statement under the Securities Act, or a similar document pursuant to any other statute then in effect corresponding to the Securities Act,
covering the registration of at least the lesser of (a) at least one third of the then outstanding Registrable Shares or (b) Registrable Shares the expected price to the public of which
equals or exceeds $5,000,000 (based on the market price or fair value on the date of such request), then the Corporation shall promptly notify all other Holders of such request and shall use its best
efforts to cause all Registrable Shares that Holders have requested be registered to be registered under the Securities Act on Form S-1 or any other available form the
use of which is approved by the Holders of a majority of the Registrable Shares that are to be included in such registration. 



        Notwithstanding
the foregoing, (i) the Corporation shall not be obligated to effect a registration pursuant to this Section 2 during the period starting with the date sixty
(60) days prior to the Corporation's estimated date of filing of, and ending on a date six (6) months following the effective date of, a registration statement pertaining to an
underwritten public offering of securities for the account of the Corporation, provided that the Corporation is actively employing in good faith its best efforts to cause such registration statement
to become effective and that the Corporation's estimate of the date of filing such registration statement is made in good faith; (ii) the Corporation shall not be obligated to effect a
registration pursuant to this Section 2 within six (6) months after the effective date of a prior registration under this Section 2; and (iii) if the Corporation shall
furnish to the Holders a certificate signed by the President of the Corporation stating that in the good faith judgment of the Board of Directors it would be seriously detrimental to the Corporation
or its stockholders for a registration statement to be filed in the near future, then the Corporation's obligation to use its best efforts to file a registration statement shall be deferred for
a period not to exceed ninety (90) days; provided, however, that the Corporation shall not be
permitted to so defer its obligation more than once in any 12-month period. 


        The
Corporation shall not be obligated to effect more than two registrations on behalf of the Holders pursuant to this Section 2. 



        SECTION
3.    Corporation Registration.    If at any time the Corporation proposes to register any of its Common Stock
under the Securities Act in connection with the public offering of such securities for its own account or for the accounts of stockholders other than Holders, solely for cash on a form that would also
permit the registration of the Registrable Shares, the Corporation shall, each such time, promptly give each Holder written notice of such determination. Upon the written request of any Holder given
within thirty (30) days after giving of any such notice by the Corporation, the Corporation shall, subject to the limitations set forth in Section 8, use its best efforts to cause to be
registered under the Securities Act all of the Registrable Shares that each such Holder has requested be registered; provided, that the Corporation
shall have the right to postpone or withdraw any registration statement relating to an offering in which the Holders are eligible to participate under this Section 3 without any liability or
obligation to the Holders under this Section 3. 


3







 



        SECTION
4.    Obligations of the Corporation.    Whenever required under Section 2, Section 3 or
Section 11 to use its best efforts to effect the registration of any Registrable Shares, the Corporation shall, as expeditiously as reasonably possible: 



        (a)   Prepare
and file with the SEC a registration statement with respect to such Registrable Shares and use its best efforts to cause such registration statement to become
effective, and, upon the request of the Holders of a majority of the Registrable Shares registered thereunder, keep such registration statement effective for a period of up to one hundred eighty
(180) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided,  however, that (i) such
180-day period shall be extended for a period of time equal to the period the Holder refrains from selling any
securities included in such registration at the request of an underwriter of Common Stock (or other securities) of the Corporation; and (ii) in the case of any registration of Registrable
Shares on Form S-3 which are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such 180-day period shall be
extended for up to ninety (90) days, if necessary, to keep the registration statement effective until all such Registrable Shares are sold. 


        (b)   Prepare
and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as
may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement. 



        (c)   Furnish
to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and
such other documents as they may reasonably request in order to facilitate the disposition of such Registrable Shares owned by them. 


        (d)   Use
its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as
shall be reasonably appropriate for the distribution of the securities covered by the registration statement, provided that the Corporation shall not be required in connection therewith or as a
condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, and further provided that (anything in this Agreement to the
contrary notwithstanding with respect to the bearing of expenses) if any jurisdiction in which the securities shall be qualified shall require that expenses incurred in connection with the
qualification of the securities in that jurisdiction be borne by selling stockholders, then such expenses shall be payable by selling stockholders pro rata, to the extent required by such
jurisdiction. 


        (e)   Provide
a transfer agent for the Common Stock no later than the effective date of the first registration of any Registrable Shares. 


        (f)    Otherwise
use its best efforts to comply with all applicable rules and regulations of the SEC. 


        (g)   Use
its best efforts either (i) to cause all such Registrable Shares to be listed on a national securities exchange (if such securities are not already so listed)
and on each additional national securities exchange on which similar securities issued by the Corporation are then listed, if the listing of such securities is then permitted under the rules of such
exchange, or (ii) to secure designation of all such Registrable Shares as a Nasdaq "national market system security" within the meaning of Rule 11Aa2-1 of the SEC or, failing
that, to secure listing on Nasdaq for such Registrable Shares and, without limiting the generality of the foregoing, to arrange for at least two (2) market makers to register as such with
respect to Registrable Shares with the National Association of Securities Dealers. 



4







 




        (h)   Enter
into such customary agreements (including an underwriting agreement in customary form) and take such other actions as the selling Holders of Registrable Shares
shall reasonably request in order to expedite or facilitate the disposition of such Registrable Shares. 



        (i)    Make
available for inspection by any selling Holder of Registrable Shares, by any underwriter participating in any disposition to be effected pursuant to such
registration statement and by any attorney, accountant or other agent retained by any such selling Holder or any such underwriter, all pertinent financial and other records and pertinent corporate
documents and properties of the Corporation, and cause all of the Corporation's officers, directors and employees to supply all information reasonably requested by any such selling Holder,
underwriter, attorney, accountant or agent in connection with such registration statement. 


        (j)    Use
every reasonable effort to prevent the issuance of any stop order suspending the effectiveness of such registration statement or of any order preventing or
suspending the use of any preliminary prospectus and, if any such order is issued, to obtain the lifting thereof at the earliest reasonable time. 


        (k)   Make
such representations and warranties to the selling Holders of Registrable Shares and the underwriters as are customarily made by issuers to selling stockholders and
underwriters, as the case may be, in primary underwritten public offerings. 




        SECTION
5.    Furnish Information.    It shall be a condition precedent to the obligations of the Corporation to take
any action pursuant to this Agreement with respect to the registration of any Holder's Registrable Shares that such Holder shall take such actions and furnish to the Corporation such information
regarding itself, the Registrable Shares held by it, and the intended method of disposition of such securities, as the Corporation shall reasonably request and as shall be required in connection with
any registration, qualification or compliance referred to in this agreement, including, without limitation (i) in connection with an underwritten offering, enter into an appropriate
underwriting agreement containing terms and provisions then customary in agreements of that nature, (ii) enter into such custody agreements, powers of attorney and related documents at such
time and on such terms
and conditions as may then be customarily required in connection with such offering and (iii) distribute the Registrable Shares only in accordance with and in the manner of the distribution
contemplated by the applicable registration statement and prospectus. In addition, the Holders shall promptly notify the Corporation of any request by the Commission or any state securities commission
or agency for additional information or for such registration statement or prospectus to be amended or supplemented. 


        SECTION
6.    Expenses of Demand Registration.    All expenses incurred in connection with any registration pursuant
to Section 2 or Section 11 (excluding underwriters' discounts and commissions), including, without limitation, all registration and qualification fees, printers' and accounting fees,
fees and disbursements of counsel for the Corporation, and the reasonable fees and disbursements of one special counsel for the selling Holders collectively, shall be borne by the Corporation whether
or not the registration statement to which such registration expenses relate becomes effective; provided,  however, that the Corporation shall not be
required to pay for any expenses of any registration proceeding begun pursuant to Section 2 if the
registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Shares to be registered (in which case all participating Holders shall bear such expenses
pro rata based upon the number of Registrable Shares that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Shares agree to forfeit their right to
one demand registration pursuant to Section 2; provided further, however, that if at the time of such withdrawal, the Holders have learned of a
material adverse change in the condition, business, or prospects of the Corporation from that known to the Holders at the time of their request and have withdrawn the request with reasonable
promptness after 


5







 



learning
of such information, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 2. 


        SECTION
7.    Corporation Registration Expenses.    All expenses (excluding underwriters' discounts and commissions)
incurred in connection with any registration pursuant to Section 3, including, without limitation, any additional registration and qualification fees and any additional fees and disbursements
of counsel to the Corporation that result from the inclusion of securities held by the selling Holders in such registration and the reasonable fees and disbursements of one special counsel for the
selling Holders collectively, shall be borne by the Corporation whether or not the registration statement to which such registration expenses relate becomes effective. 


        SECTION
8.    Underwriting Requirements.    



        (a)   In
connection with any offering under Section 3 involving an underwriting of shares being issued by the Corporation, the Corporation shall not be required to
include any Holder's Registrable Shares in such underwriting unless such Holder accepts the terms of the underwriting as agreed upon between the Corporation and the underwriters selected by it, and
then only in such quantity as will not, in the reasonable opinion of the underwriters, jeopardize the success of the offering by the Corporation. If the total amount of securities that all Holders
request to be included in an underwritten offering under
Section 3 exceeds the amount of securities that the underwriters reasonably believe compatible with the success of the offering, the Corporation may exclude some or all of the Registrable
Shares from such registration and underwriting, provided, however, that the number of Registrable Shares
of the Holders to be included in such underwriting and registration shall not be reduced unless all other securities (excluding those of the Corporation) are first entirely excluded from the
underwriting and registration. If there is a reduction of the number of Registrable Shares pursuant to this Section 8(a), such reduction shall be made pro rata based upon the aggregate number
of Registrable Shares required to be registered by such Holders. 


        (b)   With
respect to any underwriting of shares to be registered under Section 2 or Section 11, the selling Holders who initiate the request for registration
shall have the right to designate the managing underwriter or underwriters, subject to the consent of the Corporation. In connection with any underwritings of shares to be registered under
Section 3, the Corporation shall have the right to designate the managing underwriter or underwriters. In any such case, such consent of the Corporation or the Holders shall not be unreasonably
withheld or delayed. 




        SECTION
9.    Delay of Registration.    No Holder shall have any right to take any action to restrain, enjoin, or
otherwise delay any registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Agreement. 



        SECTION
10.    Indemnification.    In the event any Registrable Shares are included in a registration statement under
this Agreement: 



        (a)   To
the extent permitted by law, the Corporation will indemnify and hold harmless each Holder requesting or joining in a registration, the partners, members, officers,
directors and stockholders of such Holder, legal counsel and accountants for such Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the 1934 Act, against any losses, claims, damages or liabilities, joint or several, to which they may become subject under the
Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based on (i) any untrue or alleged untrue statement of
any material fact contained in such registration statement, including, without limitation, any prospectus or final prospectus contained therein or any amendments or supplements thereto,
(ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to 



6







 

make
the statements therein not misleading or (iii) any violation by the Corporation of any rule or regulation promulgated under the Securities Act applicable to the Corporation and relating to
action or inaction required of the Corporation in connection with any such registration; and will promptly reimburse each such Holder, underwriter, controlling person or other aforementioned person
for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, or action,  provided, however, that the indemnity agreement contained in this Section 10(a) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Corporation (which consent shall not be unreasonably
withheld or delayed) nor shall the Corporation be liable to any such Holder, underwriter, controlling person or other aforementioned person in any such case for any such loss, claim, damage, liability
or action to the extent that it (i) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in connection with such registration
statement, preliminary prospectus, final prospectus, or amendments or supplements thereto, in reliance upon and in conformity with written information furnished to the Corporation expressly for use in
connection with such registration by or on behalf of such Holder, underwriter, controlling person or other aforementioned person, (ii) is caused by the failure of such Holder to deliver a copy
of the final prospectus relating to such Registrable Shares, as then amended or supplemented, in connection with a purchase, if the Corporation had previously furnished copies thereof to such Holder
or (iii) is caused by such Holder's disposition of Registrable Shares during any period during which such Holder is obligated to discontinue any disposition of Registrable Shares under
Section 18. 


        (b)   To
the extent permitted by law, each Holder requesting or joining in a registration, severally and not jointly, will indemnify and hold harmless the Corporation, each of
its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Corporation within the meaning of the Securities Act, and any underwriter (within
the meaning of the Securities Act) for the Corporation against any losses, claims, damages or liabilities to which the Corporation or any such director, officer, controlling person or underwriter may
become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon (i) any untrue
statement or alleged untrue statement of any material fact contained in such registration statement, including any prospectus or final prospectus contained therein or any amendments or supplements
thereto or (ii) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information relating to
and furnished to the Corporation by such Holder expressly for use in connection with such registration; and will promptly reimburse the Corporation or any such director,
officer, controlling person or underwriter for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action;  provided, however, that the indemnity agreement contained in this Section 10(b) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of such Holder (which consent shall not be unreasonably withheld
or delayed) and provided further that no Holder shall have any liability under this Section 10(b) in excess of the net proceeds actually received by such Holder in the relevant public offering. 



7









  



        (c)   Promptly
after receipt by an indemnified party under this Section 10 of notice of the commencement of any action, such indemnified party will, if a claim in
respect thereof is to be made against any indemnifying party under this Section 10, notify the indemnifying party in writing of the commencement thereof and the indemnifying party shall have
the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties. The failure to notify an indemnifying party promptly of the commencement of any such action, if prejudicial to his ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this Section 10 to the extent the Indemnifying Party is prejudiced by a delay of such notification, but the omission so to
notify the indemnifying party will not relieve him of any liability that he may have to any indemnified party otherwise than under this Section 10. 


        (d)   If
the indemnification provided for in this Section 10 is required by its terms but is for any reason held to be unavailable to or otherwise insufficient to hold
harmless an indemnified party under Section 10(a) or Section 10(b) in respect of any losses, claims, damages, liabilities or expenses referred to herein, then each applicable
indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of any losses, claims, damages, liabilities or expenses referred to herein in such proportion as
is appropriate to reflect the relative fault of the Corporation and the selling Holders in connection with the statements or omissions described in such Section 10(a) or Section 10(b)
which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative fault of the Corporation and the selling Holders shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Corporation or the selling Holders and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid
or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed to include, subject to the limitations set forth in this Section 10,
any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or claim. The provisions set forth in Section 10(c) with respect
to notice of commencement of any action shall apply if a claim for contribution is to be made under this Section 10(d); provided,  however, that no
additional notice shall be required with respect to any action for which notice has been given under subsection Section 10(c)
for purposes of indemnification. The Corporation and the selling Holders agree that it would not be just and equitable if contribution pursuant to this Section 10 were determined solely by pro
rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in this paragraph. Notwithstanding the provisions of this
Section 10(d), no Holder shall be required to contribute an amount in excess of the net proceeds actually received by such Holder in the relevant public offering. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 




        SECTION
11.    Registrations on Form S-3.    



        (a)   If
(i) the Corporation shall receive a written request (specifying that it is being made pursuant to this Section 11) from one or more Holders that the
Corporation file a registration statement on Form S-3 (or any successor form to Form S-3 regardless of its designation) for a public offering of
Registrable Shares the reasonably anticipated aggregate price to the public of which would equal or exceed $1,000,000, and (ii) the Corporation is a registrant entitled to use
Form S-3 (or any successor form to Form S-3) to register such shares, then the Corporation shall promptly notify all other Holders of such request and shall use
its best efforts to cause all 



8







 

Registrable
Shares that Holders have requested be registered to be registered on Form S-3 (or any successor form to Form S-3). 


        (b)   Notwithstanding
the foregoing, (i) the Corporation shall not be obligated to effect a registration pursuant to this Section 11 during the period starting
with the date sixty (60) days prior to the Corporation's estimated date of filing of, and ending on a date six (6) months following the effective date of, a registration statement
pertaining to an underwritten public offering of securities for the account of the Corporation, provided that the Corporation is actively employing in good faith its best efforts to cause such
registration statement to become effective and that the Corporation's estimate of the date of filing such registration statement is made in good faith; (ii) the Corporation shall not be
obligated to effect a registration pursuant to this Section 11 within six (6) months after the effective date of a prior registration under this Section 11; and (iii) if
the Corporation shall furnish to the Holders a certificate signed by the President of the Corporation stating that in the good faith judgment of the Board of Directors it would be seriously
detrimental to the Corporation or its stockholders for a registration statement to be filed in the near future, then the Corporation's obligation to use its best efforts to file a registration
statement shall be deferred for a period not to exceed ninety (90) days; provided, however, that
the Corporation shall not be permitted to so defer its obligation more than once in any 12-month period. 


        (c)   The
Holders' rights to registration under this Section 11 are in addition to, and not in lieu of, their rights to registration under Section 2 and
Section 3 of this Agreement. 




        SECTION
12.    Limitation on Corporation Offerings.    The Corporation shall not register securities for sale for its
own account (or, except as permitted by Section 14, any securities other than Registrable Shares) in any registration requested pursuant to Section 2 or Section 11 unless
permitted to do so by the written consent of the Holders of a majority of the Registrable Shares as to which registration has been requested unless the inclusion of securities for the account of the
Corporation would not require a reduction in the number of Registrable Shares to be included in such registration, as determined by the managing underwriter. 


        SECTION
13.    Reports Under Securities Exchange Act of 1934.    With a view to making available to the Holders the
benefits of Rule 144 and any other rule or regulation of the SEC that may at any time
permit a Holder to sell securities of the Corporation to the public without registration, the Corporation agrees to use its best efforts to: 



        (a)   make
and keep public information available, as those terms are understood and defined in Rule 144, at all times subsequent to ninety (90) days after the
effective date of the first registration statement covering an underwritten public offering filed by the Corporation; 


        (b)   file
with the SEC in a timely manner all reports and other documents, if any, required of the Corporation under the Securities Act and the 1934 Act; and 



        (c)   furnish
to any Holder forthwith upon request a written statement by the Corporation that it has complied with the reporting requirements of Rule 144 (at any time
after ninety (90) days after the effective date of said first registration statement filed by the Corporation), and of the Securities Act and the 1934 Act (at any time after it has become
subject to such reporting requirements), a copy of the most recent annual or quarterly report of the Corporation, and such other reports and documents so filed by the Corporation as may be reasonably
requested in availing any such holder to take advantage of any rule or regulation of the SEC permitting the selling of any such securities without registration. 




        SECTION
14.    Limitations in Connection with Future Grants of Registration Rights.    Without the prior written
consent of the Holders of at least a majority in voting power of then outstanding Registrable Shares held by Investors, the Corporation shall not grant rights to any person or entity: 


9







 

(a) to
cause the Corporation to register any of such person's or entity's securities of the Corporation; (b) to include such person's or entity's securities of the Corporation in any
registration statement filed under Section 2 or Section 11 hereof; (c) to include such person's or entity's securities of the Corporation in any registration statement described
in Section 3 hereof, unless, in the case of each of (a), (b) and (c), under the terms of such agreement, such person or entity may include such securities in any such registration only
to the extent that the inclusion of his or its securities will not reduce the amount of Registrable Shares of the Holders which is included in such registration; or (d) otherwise to cause the
registration of such person's or entity's securities of the Corporation in any manner which are superior to or pari passu with the registration rights
granted herein to the Holders. 


        SECTION
15.    Transfer of Registration Rights.    The registration rights and obligations of any Holder (and of any
transferee of any Holder, or its transferees, of the rights under this Agreement in accordance with this Section 15) under this Agreement with respect to any Registrable Shares may be
transferred to any transferee who acquires (otherwise than in a registered public offering) at least five percent (5%) of the Registrable Shares then held by such Holder;  provided, however, that the transfer of registration rights to any Affiliate of any Holder will not be
subject to such requirement as to minimum shareholding; provided, further, that (a) such rights
and obligations may not be transferred to any entity
whose primary line of business is directly competitive with the primary line of business of the Corporation, as determined in good faith by the Board of Directors (b) the Corporation shall be
given written notice by the Holder at the time of any permitted transfer stating the name and address of the transferee and identifying the securities with respect to which the rights and obligations
under this Agreement are being assigned and (c) the transferee shall execute an agreement to be bound by the terms of this Agreement. For purposes of this Section 15, an "Affiliate" of
any Holder (or any transferee of any Holder) means any general or limited partner of any Holder (or transferee) that is a partnership, any member of any Holder that is a limited liability company or
any person or entity that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, such Holder or transferee. 


        SECTION
16.    Mergers, Etc.    The Corporation shall not, directly or indirectly, enter into any merger,
consolidation or reorganization in which the Corporation shall not be the surviving corporation unless the proposed surviving corporation shall, prior to such merger, consolidation or reorganization,
agree in writing to assume the obligations of the Corporation under this Agreement, and for that purpose references hereunder to "Registrable Shares" shall be deemed to be references to the securities
which the Holders would be entitled to receive in exchange for Registrable Shares under any such merger, consolidation or reorganization; provided,  however,
 that the provisions of this Agreement shall not apply in the event of any merger, consolidation or reorganization in which the Corporation is
not the surviving corporation if the holders of Registrable Shares are entitled to receive in exchange therefor (i) cash, or (ii) securities of the acquiring corporation which may be
immediately sold to the public without registration under the Securities Act. 



        SECTION
17.    Stand-Off Agreement.    Each Holder, if requested by the Corporation and the managing
underwriter of an offering by the Corporation of Common Stock pursuant to a registration statement under the Securities Act, shall agree, by executing and delivering such form of agreement as the
Corporation and such underwriter shall reasonably request, not to sell publicly or otherwise transfer or dispose of any Registrable Shares or other securities of the Corporation held by such Holder
prior to the effective date of such registration statement for a specified period of time immediately following the effective date of such registration statement, such period of time not to exceed one
hundred eighty (180) days; provided that: 



        (a)   such
one-hundred eighty (180) day period may be extended on one occasion by the managing underwriter to the extent necessary to prevent the managing
underwriter(s) from violating Section 2711(f)(4) of the rules of the National Association of Securities Dealers, Inc. 



10







 

(e.g.,
as the result of the publication or other distribution of a research report or public appearance concerning the Company); 



        (b)   such
agreement shall apply only to the initial public offering of the Corporation's securities; 


        (c)   such
agreement shall not apply to resales of the Corporation's securities purchased by a Holder in a public market, and 


        (d)   all
persons who hold shares of Common Stock, or securities convertible into or exchangeable or exercisable for shares of Common Stock, which in aggregate represent one
percent (1%) or more of the shares of Common Stock then outstanding (which 1% shall include all securities convertible into or exchangeable or exercisable for shares of Common Stock, on an as
converted, exchanged or exercised basis) (any such person, a "1% Stockholder"), and all officers and directors of the Corporation, enter into similar agreements. 




        Any
discretionary waiver or termination of the restrictions of such agreements (including this Agreement) by the Corporation or the managing underwriter (other than discretionary waivers
or releases up to an amount of $50,000 due to financial hardship) shall apply to all persons subject to such agreements on a pro rata basis, based upon the number of shares held by such persons. 


        SECTION
18.    Future Events.    The Corporation will notify each Holder participating in a registration of the
occurrence of any of the following events of which the Corporation is actually aware, and when so notified, each Holder will immediately discontinue any disposition of Registrable Shares until
notified by the Corporation that such event is no longer applicable: 



        (a)   the
issuance by the Commission or any state securities commission or agency of any stop order suspending the effectiveness of the registration statement or the
initiation of any proceedings for that purpose (in which case the Corporation will make reasonable efforts to obtain the withdrawal of any such order or the cessation of any such proceedings); or 



        (b)   the
existence of any fact which makes untrue any material statement made in the registration statement or prospectus or any document incorporated therein by reference or
which requires the making of any changes in the registration statement or prospectus or any document incorporated therein by reference in order to make the statements therein not misleading (in which
case the Corporation will make reasonable efforts to amend the applicable document to correct the deficiency). 




        SECTION
19.    Notices.    All notices, requests, consents and other communications hereunder ("Notices") to any party
shall be contained in a written instrument addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by the addressee to the addressor
listing all parties and shall be deemed given (a) when delivered in person or duly sent by fax showing confirmation of receipt, (b) three days after being duly sent by first class mail
postage prepaid (other than in the case of Notices to or from any non-U.S. resident, which Notices must be sent in the manner specified in clause (a) or (c)), or (c) two days
after being duly sent by DHL, Federal Express or other recognized express international courier service: 



        (a)   if
to the Corporation, to: 



	

	Sirtris
Pharmaceuticals, Inc.

790 Memorial Drive, Suite 104

Cambridge, MA 02139

Fax: (617) 252-6924 



11







 



	

	with
a copy to:



	

	Marc
Rubenstein

Ropes & Gray LLP

One International Place

Boston, MA 02110

Fax: (617) 951-7050 




        (b)   if
to the Investors, to their respective addresses set forth on Schedule A of this Agreement or, in the case of an
Additional Investor (as defined below), to such Additional Investor's address as set forth on the counterpart signature page hereto executed by such Additional Investor, with a copy to: 



	

	Mark
Bettencourt

Goodwin Procter LLP

Exchange Place

53 State Street

Boston, MA 02109

Fax: (617) 523-1231



	

	And



	

	Maurine
R. Bartlett

Cadwalader, Wickersham & Taft LLP

One World Financial Center

New York, NY 10281

Fax: (212) 504-6666 




        SECTION
20.    Miscellaneous.    



        (a)   This
Agreement states the entire agreement of the parties concerning the subject matter hereof, and supersedes all prior agreements, written or oral, between or among
them concerning such subject matter. Without limiting the generality of the foregoing, this Agreement amends and restates the Old Agreement in its entirety. 


        (b)   This
Agreement may be amended, and compliance with any provision of this Agreement may be omitted or waived, only by the written agreement of the Corporation and the
Holders of at least a majority in voting power of the then outstanding Registrable Shares; provided however that (i) no amendment or waiver may
treat one Investor or group of Investors more adversely than any other Investor or group of Investors without the consent of such Investor or the consent of the holders of a majority in voting power
of the then outstanding Registrable Shares held by the Investor or group of Investors adversely affected by such amendment or waiver and (ii) Section 23 of this Agreement may not be
amended or waived without the prior written consent of The Wellcome Trust Limited as trustee of the Wellcome Trust. 


        (c)   This
Agreement shall be governed by, and construed and enforced in accordance with, the substantive laws of the Commonwealth of Massachusetts, without regard to its
principles of conflicts of laws. 


        (d)   This
Agreement may be executed in any number of counterparts, each such counterpart shall be deemed to be an original instrument, and all such counterparts together
shall constitute but one agreement. Any such counterpart may contain one or more signature pages. This Agreement may be executed by facsimile signature pages. 




        SECTION
21.    Accession.    Any Additional Investor as defined in the Series C-1 Purchase
Agreement (an "Additional Investor") shall automatically become a party to this Agreement by executing and delivering to the Corporation a counterpart signature page to this Agreement in the 


12







 

form
of Exhibit A hereto, and shall thereupon be deemed an "Investor" for all purposes of this Agreement. 


        SECTION
22.    Aggregation of Stock.    All shares of Preferred Stock and Common Stock of the Corporation held or
acquired by affiliated entities or persons shall be aggregated for the purpose of determining the availability of any rights under this Agreement. 



        SECTION
23.    Wellcome Trust Limited.    With respect to its signatory capacity and liability as the trustee of the
Wellcome Trust, the Wellcome Trust Limited (the "Trustee") enters into this Agreement in its capacity as the trustee for the time being of The Wellcome Trust but not otherwise and it is hereby agreed
and declared that notwithstanding anything to the contrary contained or implied in this Agreement: 



        (a)   the
obligations incurred by the Trustee under or in consequence of this Agreement shall be enforceable against it or the other trustees of The Wellcome Trust from time
to time; and 


        (b)   the
liabilities of the Trustee (or such other trustees as are referred to in paragraph (a) above) in respect of such obligations shall be limited to such
liabilities as can, and may lawfully and properly be met out of the assets of The Wellcome Trust for the time being in the hands or under the control of the Trustee or such other trustees. 



[Remainder
of page intentionally left blank.] 


13







 

        IN
WITNESS WHEREOF, the parties have executed this Fourth Amended and Restated Registration Rights Agreement as a contract under seal as of the date first written above. 



	 	 	SIRTRIS PHARMACEUTICALS, INC.
 
	

 	
 	

By:	

/s/  CHRISTOPH WESTPHAL      
 Name: Christoph Westphal

Title: Chief Executive Officer




14








SIRTRIS PHARMACEUTICALS, INC.  


 Fourth Amended and Restated Registration Rights Agreement  


 Investor Signature Page  


        By executing this page in the space provided, the undersigned hereby agrees (i) that it is an "Investor" as defined in the Fourth Amended and Restated
Registration Rights Agreement dated as of January 23, 2007, by and among Sirtris Pharmaceuticals, Inc. and the parties named therein (the "Fourth Amended and Restated Registration Rights
Agreement"), (ii) that it is a party to the Fourth Amended and Restated Registration Rights Agreement for all purposes and (iii) that it is bound by all terms and conditions of the
Fourth Amended and Restated Registration Rights Agreement. 


        EXECUTED
this        day of January, 2007. 



	 	 	
 (print name)
	

 	
 	

By:	


	

 	
 	

Title:	













 
 

Exhibit A    
    


SIRTRIS PHARMACEUTICALS, INC.  


 Fourth Amended and Restated Registration Rights Agreement  


 Additional Investor Signature Page  


        By executing this page in the space provided, the undersigned hereby agrees (i) that it is an "Investor" as defined in the Fourth Amended and Restated
Registration Rights Agreement dated as of January 23, 2007, by and among Sirtris Pharmaceuticals, Inc. and the parties named therein (the "Fourth Amended and Restated Registration Rights
Agreement"), (ii) that it is a party to the Fourth Amended and Restated Registration Rights Agreement for all purposes and (iii) that it is bound by all terms and conditions of the Third
Amended and Restated Registration Rights Agreement. 


        EXECUTED
this        day of                        ,
[            ]. 



	 	 	
 (print name)
	

 	
 	

By:	


	

 	
 	

Title:	


	

 	
 	

Address:	


	

 	
 	


	

 	
 	












Schedule A  











QuickLinks



Exhibit 4.2




Exhibit A